-

1 Day CoRep, FinRep and Capital Adequacy Course | Navigate EU & UK Reporting Frameworks (ONLINE EVENT: August 19, 2025) - ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "CoRep, FinRep and Capital Adequacy" training has been added to ResearchAndMarkets.com's offering.

By attending this interactive 1 day course conducted by senior market practitioner, you will learn about practical reporting aspects of Common Reporting Framework (COREP) and Financial Reporting Framework (FINREP), as standardised reporting frameworks mandated by the EU EBA, and the UK PRA/FCA under the Capital Requirements Regulation (CRR). These frameworks ensure consistent and accurate reporting of financial and prudential information, enabling regulators to assess the stability and risk profiles of financial institutions.

The session covers the key challenges encountered by banks and credit institutions, and other investment firms, asset managers and hedge funds, key lessons learnt in implementing trade and transaction reporting, and successful remediation of any issues.

You will learn about all aspects of Financial reporting, from organisational scope, to data validation, data sourcing, data templates and structures, submission methodologies - and resulting impact to Front, Middle and Back Office processes.

Through interactive sessions, case studies, and hands-on exercises, you will gain the knowledge and skills required to navigate the complexities of financial reporting in a regulated environment.

The course includes regulatory guidance from the PRA/FCA, EBA and local European regulators - and UK Financial reporting post Brexit.

What will you learn

By the end of this practical training you will:

  • Understand the Regulatory Background - Purpose, Scope and Imperatives for Financial Reporting using COREP and FINREP within UK and EU Banking Regulations (Basel III, CRD IV, CRR)
  • Master Reporting frameworks for COREP and FINREP, including the data structure, key templates, and data requirements
  • Develop practical skills in implementing and reporting Prudential Reporting (COREP) and Financial Reporting (FINREP) frameworks, using case studies and real life examples

Who Should Attend:

This course is relevant for: Heads and managers of:

  • Treasury
  • Finance
  • Risk
  • Compliance
  • Audit
  • Financial Operations and Reporting
  • FP&A
  • Regulatory Affairs

Key Topics Covered:

  • Regulatory Capital and Basel 3.1/CRD IV/UK CRR
  • Pillar 1,2,3 reporting, ICAAP and ILAAP
  • COmmon REPorting Standards (COREP) - Regulatory Capital Reporting
  • FINancial REPorting Standards (FINREP) - IFRS Financial Reporting
  • Next Steps and Upcoming Regulations (Basel 3.1 "Endgame")

For more information about this training visit https://www.researchandmarkets.com/r/yw4nt8

About ResearchAndMarkets.com

ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./ CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

Research and Markets


Release Versions

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./ CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

More News From Research and Markets

$9.17 Bn Cancer Antibody Drug Conjugates Global Markets, 2019-2024, 2024-2029F, 2034F - ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "Cancer Antibody Drug Conjugates Global Market Report 2025" has been added to ResearchAndMarkets.com's offering. The global cancer antibody drug conjugates market is experiencing significant expansion, with a projected increase from $8.19 billion in 2024 to $9.17 billion in 2025, reflecting a compound annual growth rate (CAGR) of 11.9%. This growth has been fueled by the rising incidence of cancer globally, increased healthcare spending, demand for targeted treatmen...

$4.3 Bn Artificial Intelligence (AI)-Driven Smart Grid Intrusion Detection Markets, 2019-2024, 2024-2029F, 2034F - ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "Artificial Intelligence (AI)-Driven Smart Grid Intrusion Detection Market Report 2025" has been added to ResearchAndMarkets.com's offering. The AI-driven smart grid intrusion detection market is witnessing considerable growth, projected to surge from $1.76 billion in 2024 to $2.11 billion in 2025, maintaining a robust CAGR of 19.9%. Key growth drivers in the past included a rise in cyberattacks on power infrastructures, increased adoption of smart grids, regulatory...

$33.17 Bn Drug Addiction Treatment Markets, 2019-2024, 2024-2029F, 2034F - ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "Drug Addiction Treatment Market Report 2025" has been added to ResearchAndMarkets.com's offering. The "Drug Addiction Treatment Global Market Report 2025" delivers crucial intelligence for strategists, marketers, and senior management, enabling them to evaluate this burgeoning market. It's an essential resource that projects market trends over the next decade and beyond. The drug addiction treatment market has experienced rapid growth, increasing from $20.81 billio...
Back to Newsroom